The largest U.S. banks are scrutinizing members of the Federal Reserve for any insight into how the central bank will tinker interest rates.Banksread more
Facebook's cryptocurrency project has already been met with skepticism from policymakers around the world.Technologyread more
The U.S. and China restarted their trade talks, but signs are showing a comprehensive deal could be a long way off, if it happens at all.Marketsread more
Stone, 66, a notorious Republican political operative who has described himself as a "dirty trickster," had previously been dressed down by the judge for his public remarks...Politicsread more
The Biden team's second-quarter Federal Election Commission filing shows that the campaign wrote a check of just over $5,300 on June 28 to Sheehan Associates for "strategic...2020 Electionsread more
See which stocks are posting big moves after the bell on July 16.Market Insiderread more
United Airlines' second-quarter profit tops estimates but questions about the 737 Max linger.Airlinesread more
Three civil rights groups filed a federal lawsuit on Tuesday challenging the Trump administration's new asylum rule, which bars asylum claims from most noncitizens who travel...Politicsread more
Google VP of policy Karan Bhatia started sweating early as hearing chair Ted Cruz brings out an internal presentation created within the company.Technologyread more
At a hearing with the House Judiciary subcommittee on antitrust, an Amazon representative disputed a key argument about how it users sellers' data.Technologyread more
Charles Evans spoke Tuesday at CNBC's @Work Human Capital + Finance Conference in Chicago. The Fed president said he is worried about low inflation and several other issues.At Workread more
It's that time again! Jim Cramer rang the lightning round bell, which means he gave his take on caller favorite stocks at rapid speed:
Cyberark: "I know the group has gotten high risk. I didn't like that downgrade, I think Cyberark is doing well. But I've got to tell you, I understand. The high priced earnings multiple stocks have not faired that well ... but Workday did go up last night. Maybe there's hope here."
Carrizo Oil & Gas: "I think Chip Johnson [CEO] has done a good job, but I like these companies that have just done deals that are good. I like Concho. I like Concho better than Carrizo, I've got to tell you. I think that one is ready to ride. I also like Occidental for those who like a dividend. That's owned by my trust."
Clovis Oncology: "It just had that very big spike on the good news, and I don't like to chase the spike. It's got priority review for a particular kind of ovarian cancer and I think that you had to be in it last week to be honest."
Gilead Sciences: "It's not best-of-breed because they have not reinvested successfully from all that money they got from Hep C. They need to do an acquisition or they need to split the company up. One or the other. I can't recommend it."
Horizon Pharma: "Keep your powder dry here ... this is the kind of company that could easily be in the crosshairs of a tweeting politician. It doesn't mean that I think that it should, but it could be."
Genesee & Wyoming Inc: "Genesee is to me a decent railroad. I would actually prefer KSU here more than that. And/or Union Pacific."